PharmaVigilant Selected by Spectrum Pharmaceuticals, Inc. to Support 10 Studies

Published: Apr 10, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--PharmaVigilant, an e-clinical provider, today announced that US based Spectrum Pharmaceuticals has selected I-Vault as it’s electronic Trial Master File Platform. Spectrum, a pharmaceutical company focused on oncology drugs and unmet medical needs will standardize on the PharmaVigilant solution.

Back to news